NCT06732830

Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

Clinical Trial for the Evaluation of I+Med's DayDrop Advanced Ophthalmic Drop in Improving Signs and Symptoms of Mild/Moderate Dry Eye

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: i+Med S.Coop. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Clinical trial conducted with the aim of evaluating changes in the signs of dry eye through the change in the amount of tears produced, measured through the Schirmer test. It will be performed in 45 patients diagnosed with mild/moderate dry eye who meet the inclusion/exclusion criteria. Follow-up will be 12 weeks with a maximum of 4 visits.

Conditions

• Dry Eye Syndrome

Interventions

Type	Name	Description
DEVICE	DayDrop Advanced ophthalmic drop	The patient will administer 1 or 2 drops of DayDrop Advanced in each eye 3 times a day for 3 months.

Timeline

• Start date: 2022-12-21
• Primary completion: 2023-09-25
• Completion: 2023-09-25
• First posted: 2024-12-13
• Last updated: 2025-04-01

Locations

1 site across 1 country: Spain